Received: 14 October  2018; Published: 28 February 2019 

Cranial nerve III and/or VI function abnormalities associated with active herpesvirus infection: Clinical experience and literature review

I.G. Vasilyeva, Cand Sc (Biol); V.N. Zhdanova, Cand Sc (Med); N.G. Chopik, Cand Sc (Biol); T.A. Makarova, Jun Res Fellow; E.S. Galanta, Res Fellow; O.I. Tsiubko, Res Fellow

Romodanov Neurosurgery Institute, Kyiv (Ukraine)

E-mail:  vigvasileva@gmail.com

Background: The field of oculomotor abnormalities (OMA) is of clinical and social importance. There is a group of OMA of unknown etiology.

Purpose: To investigate the presence of DNA of herpesviruses venous blood of patients with OMA resulting from lesions of cranial nerves (CN) III and/or VI.

Materials and Methods: Thirty-five patients with OMA of unknown etiology underwent examination. Whole venous blood samples were collected for detection of herpes simplex virus type 1/2 (HSV1/2), cytomegalovirus (CMV), Epstein Barr virus (EBV), human herpes virus 6 (HHV6), HHV7, varicella-zoster virus (VZV), and HHV8 DNA using polymerase chain reaction.

Results: HHV7 was most common (16 patients; 45.7%), followed by EBV (5; 14.3%), HHV6 (2; 5.7%), HSV1/2 (1 patient) and CMV (1 patient). Eight patients (22.8%) were found to have two viruses. Of these, 6 had both EBV and HHV7, one had both EBV and HHV6, and one had both HHV6 and HHV7. In addition, 2 patients (5.7%) were found to have three viruses, EBV, HHV6, and HHV7.

Conclusion: For patients with OMA of unknown etiology, the venous blood should be tested by PCR for herpesviruses.

Keywords: oculomotor abnormalities, herpesviruses


  1. Kochina ML, Demin YuA, Kovtun NM, Kaplin IV. [Peculiarities of interferential pictures of eyes at horizontal heterotropy]. Ukrainskiy zhurnal meditsiny, biologii i sportu. 2017 Mar; 2(4):75-81. Russian.
  2. Kovtun NM. [Interference Patterns of the Eye Cornea with Different States of Oculomotor Muscle]. Ukrainskiy zhurnal meditsiny, biologii i sportu. 2017; 6(8):81-6. Russian.
  3. Jacobson DM, Trobe JD. The emerging role of magnetic resonance angiography in the management of patients with third cranial nerve palsy. Am J Ophthalmol. 1999 Jul;128(1):94-6.
  4. Slepowa OS, Svetlova EV, Kovaleva LA, et al. [PCR study of the human herpes virus type 6 and other viruses of the herpes group in eye diseases]. Vopr Virusol. 2015;60(6):45-8. Russian.
  5. Zhu L, Zhu H. Ocular herpes: the pathophysiology, management and treatment of herpetic eye diseases. Virol Sin. 2014 Dec;29(6):327-42. doi: 10.1007/s12250-014-3539-2. Epub 2014 Dec15.
  6. Sugita S, Shimizu N, Watanabe K, Ogawa M, Maruyama K, Usui N, Mochizuki M. Virological analysis in patients with human herpes virus 6-associated ocular inflammatory disorders. Invest Ophthalmol Vis Sci. 2012 Jul 12;53(8):4692-8. doi: 10.1167/iovs.12-10095.
  7. Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Tauber J, Sainz de la Maza MT, Foster CS. Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35 cases. Ophthalmology. 2012 Jul;119(7):1460-4. doi: 10.1016/j.ophtha.2012.01.033.
  8. Dyson H, Shimeld C, Hill TJ, Blyth WA, Easty DL. Spread of herpes simplex virus within ocular nerves of the mouse: demonstration of viral antigen in whole mounts of eye tissue. J Gen Virol. 1987 Dec;68 ( Pt 12):2989-95. doi:10.1099/0022-1317-68-12-2989
  9. Shanehsazzadeh M, Rad JS, Pourazar A, Behbahani M. Epidemiology of herpes human virus 6 and 7 infections in salivary gland neoplasms in Isfahan, Iran. Med Arch. 2014 Aug;68(4):276-8. doi: 10.5455/medarh.2014.68.276-278.
  10. El-Habashi N, Kato Y, El-Nahass E, Fukushi H, Hirata A, Sakai H, Kimura J, Yanai T. An ocular infection model using suckling hamsters inoculated with equineherpesvirus 9 (EHV-9): kinetics of the virus and time-course pathogenesis of EHV-9-induced encephalitis via the eyes. Vet Pathol. 2013 Jan;50(1):56-64. doi: 10.1177/0300985812442691.
  11. Higaki S, Fukuda M, Shimomura Y. Virological and molecular biological evidence supporting herpes simplex virus type 1 corneal latency. Jpn J Ophthalmol. 2015 Mar;59(2):131-4. doi: 10.1007/s10384-014-0369-6.
  12. Borkar DS, Gonzales JA, Tham VM, Esterberg E, Vinoya AC, Parker JV, Uchida A, Acharya NR. Association between atopy and herpetic eye disease: results from the pacific ocular inflammation study. JAMA Ophthalmol. 2014 Mar;132(3):326-31. doi: 10.1001/jamaophthalmol.2013.6277.
  13. Jester JV, Morishige N, Ben Mohamed L, Brown DJ, Osorio N, Hsiang C, Perng GC, Jones C, Wechsler SL. Confocal Microscopic Analysis of a Rabbit Eye Model of High-Incidence RecurrentHerpes Stromal Keratitis. Cornea. 2016 Jan;35(1):81-8. doi: 10.1097/ICO.0000000000000666.
  14. Harberts E, Yao K, Wohler JE, Maric D, Ohayon J, Henkin R, Jacobson S.. Human herpesvirus-6 entry into the central nervous system through the olfactory pathway. Proc Natl Acad Sci USA. 2011 Aug 16; 108(33):13734-9. doi.org/10.1073/pnas.1105143108.
  15. Velázquez Benito A, Santos Lasaosa S, Viloria Alebesque A, García Arguedas C. Multiple involvement of cranial nerves by an uncommon pathogen: humanherpesvirus type 7. Med Clin (Barc). 2011 Nov 26;137(14):667-8. doi: 10.1016/j.medcli.2011.02.030.
  16. Grassin M, Rolland A, Leboucq N, Roubertie A, Rivier F, Meyer P. Bilateral facial nerve palsy associated with Epstein-Barr virus infection in a 3-year-old boy. Arch Pediatr. 2017 Jun;24(6):564-567. doi: 10.1016/j.arcped.2017.03.009.
  17. Papageorgiou E, Ch'ng S, Kulkarni A, Anwar S, Empeslidis T. Fourth cranial nerve palsy and bilateral acute retinal necrosis following human herpesvirus 6 infection of the central nervous system. Ocul Immunol Inflamm. 2014 Jun;22(3):228-32. doi: 10.3109/09273948.2013.856533.
  18. Tesini BL, Epstein LG, Caserta MT. Clinical impact of primary infection with roseoloviruses. Curr Opin Virol. 2014 Dec;9:91-6. doi: 10.1016/j.coviro.
  19. Miyazaki Y, Namba H, Torigoe S, Watanabe M, Yamashita N, Ogawa  H, Morishima T, Yamada M. Monitoring of human herpesviruses-6 and -7 DNA in saliva samples during the acute and convalescent phases of exanthem subitum. J Med Virol. 2017 Apr;89(4):696-702. doi: 10.1002/jmv.24690.
  20. Roush KS, Domiati-Saad RK, Margraf LR, Krisher K, Scheuermann RH, Rogers BB, Dawson DB. Prevalence and cellular reservoir of latent human herpesvirus 6 in tonsillar lymphoid tissue. Am J Clin Pathol.  2001 Nov;116(5):648–654. doi.org/10.1309/Y2HH-B1CK-0F5L-U7B8.
  21. Krug LT, Pellett PE. Roseolovirus molecular biology: recent advances. Curr Opin Virol. 2014 Dec;9:170-7. doi: 10.1016/j.coviro.2014.10.004.
  22. Kawamura Y, Nakayama A, Kato T, Miura H, Ishihara N, Ihira M, Takahashi Y, Matsuda K, Yoshikawa T. Pathogenic Role of Human Herpesvirus 6B Infection in Mesial Temporal Lobe Epilepsy. J Infect Dis. 2015 Oct 1;212(7):1014-21. doi: 10.1093/infdis/jiv160.
  23. Szewc AM, Taylor S, Cage GD, Jacobsen J, Bulut OP, de Mello Acute Liver Failure in an Adolescent Male Induced by Human Herpesvirus 6 (HHV-6): A Case Report With Literature Review. DE(3). Lab Med. 2018 Mar 21;49(2):165-174. doi: 10.1093/labmed/lmx088.
  24. Caruso A, Rotola A, Comar M, Favilli F, Galvan M, Tosetti M, Campello C, Caselli E, Alessandri G, Grassi M, Garrafa E, Cassai E, Di Luca D. HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J Med Virol. 2002 Aug ;67(4):528–33. doi.org/10.1002/jmv.10133.
  25. Kondo K, Kondo T, Okuno T, Takahashi M, Yamanishi K.. Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol. 1991 Jun; 72(Pt 6):1401-8. doi.org/10.1099/0022 -1317-72-6-1401.
  26. Chi J, Gu B, Zhang C, Peng G, Zhou F, Chen Y, Zhang G, Guo Y, Guo D, Qin J, Wang J, Li L, Wang F, Liu G, Xie F, Feng D, Zhou H, Huang X, Lu S, Liu Y, Hu W, Yao K. Human herpesvirus 6 latent infection in patients with glioma. J Infect Dis. 2012 Nov;206(9):1394-8. doi: 10.1093/infdis/jis513. Epub 2012 Sep7.
  27. Luppi M, Barozzi P, Morris C, Maiorana A, Garber R, Bonacorsi G, Donelli A, Marasca R, Tabilio A, Torelli G.. Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J Virol. 1999 Jan;73(1):754–9.  
  28. Andre-Garnier E, Milpied N, Boutolleau D, Saiagh S, Billaudel S, Imbert-Marcille BM. Reactivation of human herpesvirus 6 during ex vivo expansion of circulating CD34_haematopoietic stem cells. J Gen Virol. 2004 Nov;85(Pt 11):3333-6. doi.org/10.1099/vir.0.80319-0.
  29. Marseglia L, Manti S, D Angelo G, Stroscio G, Impollonia D, Arena  S, Salpietro C, Gitto E. Human herpesviruses-6 and -7 encephalitis in immunocompetent infants: are they really so uncommon? J Biol Regul Homeost Agents. 2016 Oct-Dec;30(4):1131-1136. 
  30. Riva N, Franconi I, Meschiari M, Franceschini E, Puzzolante C,Cuomo G, Bianchi A(, Cavalleri F, Genovese M, Mussini C. Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature. Infection. 2017 Jun;45(3):385-388. doi: 10.1007/s15010-017-1014-3.
  31. Killick J, Morisse G(1)(2), Sieger D(2), Astier AL(3)(4). Complement as a regulator of adaptive immunity. Semin Immunopathol. 2018 Jan;40(1):37-48. doi: 10.1007/s00281-017-0644-y.
  32. Takemoto M, Yamanishi K, Mori Y. Human herpesvirus 7 infection increases the expression levels of CD46 and CD59 in target cells. J Gen Virol. 2007 May;88(Pt 5):1415-22. doi: 10.1099/vir.0.82394-0
  33. Boeckh M, Nichols WG. Immunosuppressive effects of beta-herpesviruses. Herpes. 2003 May;10(1):12-6. PMID: 12749798  
  34. Nastke MD, Becerra A, Yin L, Dominguez-Amorocho O, Gibson L, Stern LJ, Calvo-Calle JM. Human CD4_ T cell response to human herpesvirus 6. J Virol. 2012 May; 86(9):4776-92.  doi.org/10.1128/JVI .06573-11.
  35. Gerdemann U, Keukens L, Keirnan JM, Katari UL, Nguyen CT, de Pagter AP, Ramos CA, Kennedy-Nasser A, Gottschalk SM, Heslop HE, Brenner MK, Rooney CM, Leen AM.. Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation. Blood. 2013 Jan ;121(1):207-18. doi.org/10 .1182/blood-2012-05-430413.
  36. Martin LK, Schub A, Dillinger S, Moosmann A. Specific CD8+ T cells recognize human herpesvirus 6B. Eur J Immunol. 2012 Nov; 42(11):2901-12. doi.org/10.1002/eji.201242439.
  37. Yamanishi K, Mori Y, Pellett PE.. Human herpesviruses 6 and 7. In Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA, Racaniello VR, Roizman B (ed), Fields virology, 6th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA. 2013; p. 2058–2079.
  38. Mori Y. Recent topics related to human herpesvirus 6 cell tropism. Cell Microbiol. 2009 Jul;11(7):1001-6. doi: 10.1111/j.1462-5822.2009.01312.x.
  39. Tanaka Y, Suenaga T, Matsumoto M, Seya T, Arase H. Herpesvirus 6 glycoproteins B (gB), gH, gL, and gQ are necessary and sufficient for cell-to-cell fusion. J Virol. 2013 Oct;87(19):10900-3. doi: 10.1128/JVI.01427-13. Epub 2013 Jul 24.
  40. Secchiero P, Flamand L, Gibellini D, Falcieri E, Robuffo I, Capitani S, Gallo RC, Zauli G. Human Herpesvirus 7 induces CD4(+) T-cell death by two distinct mechanisms:necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells. Blood. 1997 Dec 1;90(11):4502-12. PMID: 9373261
  41. Cassiani-Ingoni R, Greenstone HL, Donati D, Fogdell-Hahn A, Martinelli E, Refai D, Martin R, Berger EA, Jacobson S. CD46 on glial cells can function as a receptor for viral glycoprotein-mediated cell-cell fusion. Glia. 2005 Nov 15;52(3):252-8. doi:10.1002/glia.20219
  42. He J, McCarthy M, Zhou Y, Chandran B, Wood C. Infection of primary human fetal astrocytes by human herpesvirus 6. J Virol. 1996 Feb;70(2):1296-300. PMID: 8551599  
  43. Klein G, Klein E, Kashuba E. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes. Biochem Biophys Res Commun. 2010 May; 396, 67–73. doi: 10.1016/j.bbrc.2010.02.146
  44. Chesnokova LS, Jiang R, Hutt-Fletcher LM. Viral Entry. Curr Top Microbiol Immunol. 2015;391:221-35. doi: 10.1007/978-3-319-22834-1_7.
  45. Hannan JP. The Structure-Function Relationships of Complement Receptor Type 2 (CR2; CD21). Curr Protein Pept Sci. 2016 Feb;17(5):463-87. PMID: 26916158
  46. Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD. Human complement receptor type 1/CD35 is an Epstein-Barr virus receptor. Cell Rep. 2013 Feb; 3,371–85. doi: 10.1016/j.celrep.2013.01.023.
  47. Gurbuz F, Gurbuz B, Çayir A, Tezer H. Epstein-barr virus encephalitis in infancy. West Indian Med J. 2014 Mar;63(2):206-7. doi: 10.7727/wimj.2014.021.
  48. Laurence M, Benito-León J. Epstein-Barr virus and multiple sclerosis: Updating Pender's hypothesis. Mult Scler Relat Disord. 2017 Aug;16:8-14. doi: 10.1016/j.msard.2017.05.009.
  49. Ito H, Sayama S, Irie S, Kanazawa N, Saito T, Kowa H, Haga S, Ikeda K. Antineuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infection. Neurology. 1994 Aug;44(8):1506-7.PMID: 8058157
  50. Jenson HB. Epstein-Barr virus. Pediatr Rev. 2011 Sept;32:375–83.doi: 10.1542/pir.32-9-375
  51. Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol. 2015 Jan;235(2):323-33. doi: 10.1002/path.4448.
  52. Van Samkar A, Poulsen MNF, Bienfait HP, Van Leeuwen RB. Acute cerebellitis in adults: a case report and review of the literature. BMC Res Notes. 2017 Nov 22;10(1):610. doi: 10.1186/s13104-017-2935-8.
  53. Hussain RS, Hussain NA. Ataxia and Encephalitis in a Young Adult with EBV Mononucleosis: A Case Report. Case Rep Neurol Med. 2013 May;2013:516325.doi: 10.1155/2013/516325
  54. Jha HC, Mehta D, Lu J, El-Naccache D, Shukla SK, Kovacsics C, Kolson D, Robertson ES. Gammaherpesvirus Infection of Human Neuronal Cells. MBio. 2015 Dec 1;6(6):e01844-15. doi: 10.1128/mBio.01844-15.
  55. Kano K, Katayama T, Takeguchi S, Asanome A, Takahashi K, Saito T, Sawada J, Saito M, Anei R, Kamada K, Miyokawa N, Nishihara H, Hasebe N. Biopsy-proven case of Epstein-Barr virus (EBV)-associated vasculitis of the central nervous system. Neuropathology. 2017 Jun;37(3):259-264. doi: 10.1111/neup.12356.
  56. Mazur-Melewska K, Breńska I, Jończyk-Potoczna K, Kemnitz P, Pieczonka-Ruszkowska I, Mania A, Służewski W, Figlerowicz M. Neurologic Complications Caused by Epstein-Barr Virus in Pediatric Patients. J Child Neurol. 2016 May;31(6):700-8. doi: 10.1177/0883073815613563.